Endo enters LatAm with Mexico pharma acquisition
US pharmaceutical company Endo International has turned to Creel, García-Cuéllar, Aiza y Enriquez SC and the New York and London offices of Skadden, Arps, Slate, Meagher & Flom LLP to acquire Mexico's Grupo Farmaceutico Somar in a bid to take advantage of rapid growth in Latin America’s pharmaceutical sector in the coming years.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.